• News
  • Finance

Roche to Buy Seragon for Up to $1.7 Billion for Cancer Drugs

July 2 (Bloomberg) -- Roche Holding AG, the world’s biggest maker of cancer drugs, agreed to buy Seragon Pharmaceuticals Inc. for as much as $1.7 billion to gain a new generation of experimental treatments for breast tumors.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments
Subscribe Today!